Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.
New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144.
Extremely low viral reservoir in treated chronically HIV-1-infected individuals.
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
HIV-1 Nef Targets HDAC6 to Assure Viral Production and Virus Infection.
Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals.
Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection.
HIV Research for Prevention 2018: From Research to Impact Conference Summary and Highlights.
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection.